Metraipolis › archive › dc_220fcfcc026b
Advancing MSC-EV Therapies: Harnessing Preconditioning and Mito-EVs to Tackle Neuroinflammation and Neurodegeneration — Europe PMC PMID:42357346
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42357346
- DOI
- 10.3390/pharmaceutics18060730
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T13:17:07.042Z
- SHA-256 of the archived text
48123557a6cb030bba5dcc06b9b024d3b6397d885eb4183c1cc09a7cd90c94ca- Stable URL of this page
https://metraipolis.com/documento/dc_220fcfcc026b
How to cite
Advancing MSC-EV Therapies: Harnessing Preconditioning and Mito-EVs to Tackle Neuroinflammation and Neurodegeneration — Europe PMC PMID:42357346 — Europe PMC (en), https://europepmc.org/article/MED/42357346 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_220fcfcc026b (Metraipolis archive dc_220fcfcc026b, sha256 48123557a6cb030bba5dcc06b9b024d3b6397d885eb4183c1cc09a7cd90c94ca)
BibTeX
@misc{dc220fcfcc026b,
title = {Advancing MSC-EV Therapies: Harnessing Preconditioning and Mito-EVs to Tackle Neuroinflammation and Neurodegeneration — Europe PMC PMID:42357346},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42357346},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_220fcfcc026b; sha256 48123557a6cb030bba5dcc06b9b024d3b6397d885eb4183c1cc09a7cd90c94ca},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42357346. Agents can read the archived copy with the MCP tool read_document.